Autopsy report · NCT06123325
Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
Cause of deathRegulatory or ethics
“IRB approval has lapsed. Study has submitted continuing review report for re-certification. Awaiting IRB re-approval.”
Life of this trial
- Suspended: paused, and may or may not restart.
- 120 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Montefiore Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Anxiety Depression; Aneurysm Cerebral; Mental Health Wellness 1
- Interventions
- Clipping; Endovascular embolization; Surveillance imaging
- Participants
- 120 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
“IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study suspended pending analysis” - Changes in Bleeding and Clotting During the Menstrual Cycle
“IRB Approval lapsed” - Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
“Study halted prematurely; IRB approval not obtained” - The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention
“IRB approval expired on 3/16/2022. Study would need to be reapproved by the IRB with a new submission given the duration of expiration.” - Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
“did not move forward with IRB approval, competing study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.